Droxidopa Capsule
Product Images NDC 59651-375

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 59651-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Droxidopa Fig1)

This data presents the baseline value of 5.1 and the units in both groups. The focus is on the drug Droxidopa and the mean change in dizziness which is -3.5. The treatment phase lasts for 8 weeks, with the first 4 weeks being the double-blind phase.*

FDA Label Image

Figure2 (Droxidopa Fig2)

FDA Label Image

Package Label.principal Display Panel- 100 mg (90 Capsules Bottle) (Droxidopa Fig3)

This is a prescription drug. The name of the drug is Droxidopa Capsules, and the manufacturer is Aurobindo Pharma USA, Inc. Each bottle contains 90 capsules, and each capsule has 100mg Droxidopa. The usual dosage is specified in the prescribing information. It should be stored at a temperature between 20°C to 25°C and dispensed in a tightly closed container. A warning has been given to keep it out of the reach of children. The drug is made in India. There is additional text regarding the printing zone and a coding area.*

FDA Label Image

Package Label.principal Display Panel- 200 mg (90 Capsules Bottle) (Droxidopa Fig4)

Droxidopa Capsules are available in a 90-capsule container, with each capsule containing 200 mg of droxidopa. It is recommended to see prescribing information for the usual dosage. The medication must be stored in a tight, light-resistant container at a controlled room temperature. The manufacturer warns not to use if the printed seal under the cap is broken or missing and to keep the medication out of reach of children. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. There is an overprinting zone and coding area on the packaging.*

FDA Label Image

Package Label.principal Display Panel- 300 mg (90 Capsules Bottle) (Droxidopa Fig5)

Droxidopa capsules contain 300mg per capsule and are available in a bottle of 90 capsules. The capsules should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F). Keep out of reach of children, and do not use if the printed seal under the cap is broken or missing. Usual dosage instructions can be found in the prescribing information. Distributed by Aurobindo Pharma USA and made in India.*

FDA Label Image

Chemical Structer (Droxidopa Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.